RHOA and neoplasm: In contrast, NF2 or LATS1/2 knockdown or YAP overexpression, which modeled recurrent human tumor lesions in the Hippo pathway3, altered this homeostatic balance in the MCF10A model without detectably altering physiological RhoA mechano-signaling.